Novo Nordisk Limited

Broadfield Park, Brighton Road, Crawley, West Sussex, RH11 9RT
Telephone: +44 (0)1293 613555
Fax: +44 (0)1293 613535
Medical Information Direct Line: +44 (0)845 600 5055
Medical Information e-mail: ukmedicalinfo@novonordisk.com
Customer Care direct line: +44 (0)845 600 5055
Medical Information Fax: +44 (0)1293 613211

Patient Information Leaflet last updated on the eMC: 18/08/2011
PIL Levemir Penfill

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 27/10/2010 and displayed until 18/08/2011
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to dosage and administration
Updated on 28/01/2010 and displayed until 27/10/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
Updated on 06/05/2008 and displayed until 28/01/2010
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 05/11/2007 and displayed until 06/05/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 05/11/2007 and displayed until 05/11/2007
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
Updated on 22/09/2006 and displayed until 05/11/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   insulin detemir